- 1.What are the indications for N-acetylcysteine (NAC) in the acetaminophen overdose patient with a known time of acute ingestion who can be risk stratified by the Rumack-Matthew nomogram?
- 2.What are the indications for NAC in the acetaminophen overdose patient who cannot be risk stratified by the Rumack-Matthew nomogram?
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Emergency NursingReferences
- Acetaminophen poisoning: a case report of the use of acetylcysteine.Am J Hosp Pharm. 1976; 35: 964-967
- Acetaminophen overdose: a 48-hour intravenous N-acetylcysteine treatment protocol.Ann Emerg Med. 1991; 20: 1058-1063
- Efficacy of oral versus intravenous N-acetylcysteine in acetaminophen overdose: results of an open-label clinical trial.J Pediatr. 1998; 132: 149-152
- Oral or intravenous N-acetylcysteine: which is the treatment of choice for acetaminophen (paracetamol) poisoning?.J Toxicol Clin Toxicol. 1999; 37: 759-767
- Shorter duration of oral N-acetylcysteine therapy for acute acetaminophen overdose.Ann Emerg Med. 2000; 35: 363-368
- The intravenous use of oral acetylcysteine (mucomyst) for the treatment of acetaminophen overdose.Arch Intern Med. 2002; 162: 96-97
- A 20-hour treatment for acute acetaminophen overdose.N Engl J Med. 2003; 348: 2471-2472
- Comparison of oral and i.v. acetylcysteine in the treatment of acetaminophen poisoning.Am J Health Syst Pharm. 2006; 63: 1821-1827
- The use of ondansetron in the treatment of nausea and vomiting associated with acetaminophen poisoning.J Toxicol Clin Toxicol. 1996; 34: 163-167
- Use of ondansetron and other antiemetics in the management of toxic acetaminophen ingestions.J Toxicol Clin Toxicol. 1998; 36: 19-25
- Effect of metoclopramide dose on preventing emesis after oral administration of N-acetylcysteine for acetaminophen overdose.J Toxicol Clin Toxicol. 1999; 37: 35-42
- A prospective evaluation of the effect of activated charcoal before oral N-acetylcysteine in acetaminophen overdose.Ann Emerg Med. 1994; 23: 519-523
- Management of anaphylactoid reactions to intravenous N-acetylcysteine.Ann Emerg Med. 1998; 31: 710-715
- The Australasian Clinical Toxicology Investigators Collaboration randomized trial of different loading infusion rates of N-acetylcysteine.Ann Emerg Med. 2005; 45: 402-408
- Fatal anaphylactoid reaction to N-acetylcysteine: caution in patients with asthma.Emerg Med J. 2002; 19: 594-595
- Acetaminophen poisoning and toxicity.Pediatrics. 1975; 55: 871-876
- Acetaminophen overdose: 662 cases with evaluation of oral acetylcysteine treatment.Arch Intern Med. 1981; 141: 380-385
- Prospective evaluation of repeated supratherapeutic acetaminophen (paracetamol) ingestion.Ann Emerg Med. 2004; 44: 393-398
- Acetaminophen poisoning: an evidence-based consensus guideline for out-of-hospital management.Clin Tox. 2006; 44: 1-18
- Acetaminophen toxicity in an urban county hospital.N Engl J Med. 1997; 337: 1112-1117
- Population-based incidence and outcome of acetaminophen poisoning by type of ingestion.Acad Emerg Med. 1999; 6: 1115-1120
- Clinical policy for the initial approach to patients presenting with acute toxic ingestion or dermal or inhalation exposure.Ann Emerg Med. 1999; 33: 735-761
- The origins, benefits, harms, and implications of emergency medicine clinical policies.Ann Emerg Med. 1993; 22: 597-602
- Intravenous N-acetylcysteine: the treatment of choice for paracetamol poisoning.BMJ. 1979; 2: 1097-1100
- Efficacy of oral N- acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985).N Engl J Med. 1988; 319: 1557-1562
- Safety of late acetylcysteine treatment in paracetamol poisoning.Hum Exp Toxicol. 1990; 9: 25-27
- Treating acute acetaminophen poisoning with acetylcysteine.JAMA. 1977; 237: 2406-2407
- Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine.Lancet. 1977; 310: 432-434
- Intravenous N-acetylcysteine for paracetamol poisoning.Med J Aust. 1980; 1: 664-665
- Intravenous acetylcysteine in paracetamol-induced fulminant hepatic failure: a prospective controlled trial.BMJ. 1991; 303: 1026-1029
- Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine.Lancet. 1990; 335: 1572-1573
- Tylenol Extended Relief overdose.Ann Emerg Med. 1997; 30: 104-108
- Late increase in acetaminophen concentration after overdose of Tylenol Extended Relief.Ann Emerg Med. 1996; 28: 549-551
- Acetaminophen hepatotoxicity in alcoholics. A therapeutic misadventure.Ann Intern Med. 1986; 104: 399-404
- Liver toxicity after acetaminophen ingestion. Inadequacy of the dose estimate as an index of risk.JAMA. 1977; 238: 500-501
- Severe hepatic damage after acetaminophen use in psittacosis.Am J Med. 1983; 74: 349-352
- Chronic acetaminophen toxicity: a case report and review of the literature.J Emerg Med. 2002; 23: 253-256
- Combined hepatic and renal injury in alcoholics during therapeutic use of acetaminophen.Arch Intern Med. 1985; 145: 2019-2023
- Acetaminophen hepatotoxicity in the alcoholic.South J. Med. 1990; 83: 1047-1049
- Clinical features of acetaminophen toxicity.J Clin Gastroenterol. 1988; 10: 76-80
- Late presentation of acetaminophen hepatotoxicity.Dig Dis Sci. 1982; 27: 370-374
- Hepatotoxicity after prolonged use of acetaminophen: a case report.Bol Asoc Med P R. 1988; 80: 417-419
- Concomitant alcohol and drug abuse enhancing acetaminophen toxicity. Report of a case.Am J Gastroenterol. 1978; 70: 385-388
- Centrilobular hepatic fibrosis following acetaminophen-induced hepatic necrosis in an alcoholic.JAMA. 1986; 255: 2636-2637
- Alcoholism, nonprescription drug and hepatotoxicity. The risk from unknown acetaminophen ingestion.Am J Gastroenterol. 1981; 76: 530-533
- Anuras, Chronic excessive acetaminophen use and liver damage.Ann Intern Med. 1977; 87: 299-301
- Acetaminophen associated hepatic injury, report of two cases showing unusual portal tract reactions.Hum Pathol. 1980; 11: 37-42
- Enhanced toxicity of acetaminophen in alcoholics: report of three cases.J Clin Gastroenterol. 1985; 7: 55-59
- Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial.JAMA. 2006; 296: 87-93
- Severe liver damage caused by therapeutic doses of acetaminophen.Acta Med Scand. 1987; 222: 285-288
- Hepatotoxicity associated with chronic acetaminophen administration in patients without risk factors.Ann Pharmacother. 2002; 36: 331-333
- Failure of physicians to recognize acetaminophen hepatotoxicity in chronic alcoholics.Arch Intern Med. 1991; 151: 1189-1191
- Effect of maximal daily doses of acetaminophen on the liver of alcoholic patients: a randomized, double-blind, placebo-controlled trial.Arch Intern Med. 2001; 161: 2247-2252
- Acetaminophen in chronic liver disease.Clin Pharmacol Ther. 1983; 33: 95-101
- Treatment of pain or fever with paracetamol (acetaminophen) in the alcoholic patient: a systematic review.Am J Ther. 2000; 7: 123-134
Article info
Footnotes
Reprinted from Wolf SJ, Heard K, Sloan EP, Jagoda AS. American College of Emergency Physicians Clinical Policies Subcommittee. Clinical policy: critical issues in the management of patients presenting to the emergency department with acetaminophen overdose. Ann Emerg Med. 2007;50:292-313. Reprinted with permission from the American College of Emergency Physicians.
Policy statements and clinical policies are the official policies of the American College of Emergency Physicians and, as such, are not subject to the same peer review process as articles appearing in the print journal. Policy statements and clinical policies of ACEP do not necessarily reflect the policies and beliefs of Annals of Emergency Medicine and its editors.
Members of the American College of Emergency Physicians Clinical Policies Committee (Oversight Committee):
- Andy S. Jagoda, MD (Chair 2003-2006, Co-Chair 2006-2007)
- Wyatt W. Decker, MD (Co-Chair 2006-2007)
- Deborah B. Diercks, MD
- Jonathan A. Edlow, MD
- Francis M. Fesmire, MD
- Steven A. Godwin, MD
- Sigrid A. Hahn, MD
- John M. Howell, MD
- J. Stephen Huff, MD
- Thomas W. Lukens, MD, PhD
- Donna L. Mason, RN, MS, CEN (ENA Representative 2004-2006)
- Michael Moon, RN, CNS, MSN, CEN (ENA Representative 2004)
- Anthony M. Napoli, MD (EMRA Representative 2004-2006)
- Devorah Nazarian, MD
- Jim Richmann, RN, BS, MA(c), CEN (ENA Representative 2006-2007)
- Scott M. Silvers, MD
- Edward P. Sloan, MD, MPH
- Molly E. W. Thiessen, MD (EMRA Representative 2006-2007)
- Robert L. Wears, MD, MS (Methodologist)
- Stephen J. Wolf, MD
- Cherri D. Hobgood, MD (Board Liaison 2004-2006)
- David C. Seaberg, MD, CPE (Board Liaison 2006-2007)
- Rhonda R. Whitson, RHIA, Staff Liaison, Clinical Policies Committee and Subcommittees
Approved by the ACEP Board of Directors, June 13, 2007
Supported by the Emergency Nurses Association, July 22, 2007